ArticleGigaScience2026
Context-aware simulation enables systematic optimization of long-read mapping parameters.
Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Long-read mapping performance is critical for downstream genomic analyses but remains sensitive to parameter selection. We present CycSim, a context-aware long-read simulator that learns sequence-context-dependent error profiles from empirical data and generates realistic simulated reads. CycSim more faithfully recapitulated real long-read characteristics than existing simulators, providing a high-fidelity simulation framework with known ground truth. Using this framework, we identified a Cyclone-specific parameter set that achieved 2.78-fold faster mapping than an ONT-oriented baseline while maintaining comparable variant-calling performance. For SV-oriented optimization, CycSim-guided refinement improved mapping efficiency by 8.14-34.16% across ONT, HiFi, and Cyclone HG002 datasets; increased SV F1 scores by 0.57-1.75 percentage points; and showed consistent improvements across independent benchmark datasets and different SV callers. Together, these results demonstrate the utility of CycSim for platform- and analysis-goal-specific algorithm development, benchmarking, and parameter optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.